11 March 2021PatentsMuireann Bolger

Australia to safeguard tech IP by policing foreign R&D

Australia has unveiled plans to expand the technologies in which international research and development (R&D) collaboration will face increased scrutiny to protect the country’s IP.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Jurisdiction reports

Strategies for generic/biosimilar market entry in Australia

23 September 2021 After surviving the Great Patent Cliff of 2011–2016, the pharma/biopharma industry finds itself in the Second Great Patent Cliff of 2019–2024. With it we find low-hanging fruit for generic/biosimilar market entrants, and the importance of having an elegant patent strategy enabling early market entry for generics and biosimilars is underscored.

Jurisdiction reports

Australia: Is there an Australian rocket docket for pharma?

10 November 2021 Australian Federal Court judges are prepared to expedite patent disputes when they are satisfied that the commercial reality requires it, and to use case management strategies to avoid foreseeable litigation quagmires. While there is no “rocket docket” in Australia, we have seen complex pharma patent disputes set down for hearing within five, ten and 11 months of filing in the New South Wales and Victorian registries.

Trademarks

Applying the Rogers test: A step too far?

6 July 2022 US courts have for decades applied the test to safeguard expressive works, but debate is raging over its scope and potential danger to trademarks. Muireann Bolger reports.

UK firms Venner Shipley and AA Thornton combine

UPC docs 'excessively redacted' under GDPR claims transparency lawyer

L'Oréal sued over virtual makeup try-on simulator

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Q&A: EagleView counsel maps out route to IPR victory

WIPO in Saudi Arabia to finalise design law treaty

Douwe Egberts enjoys double shot over Nestlé in coffee patent rivalry

Startup CFO’s betrayal is a lesson in preparing for the worst

Australia to safeguard tech IP by policing foreign R&D

More on this story

Editor's picks

Editor's picks

More articles